Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis.

Authors:
Yamada T; Wakabayashi M; Yamaji T; Chopra N; Mikami T and 2 more

Journal:
Clin Chim Acta

Publication Year: 2020

DOI:
10.1016/j.cca.2020.06.008

PMCID:
PMC7832771

PMID:
32533986

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Clin Chim Acta

Abbreviation: Clin Chim Acta

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Chemistry, Clinical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Time series analysis revealed prognostic value of continuous nasopharyngeal SARS-CoV-2 nucleic acid…
Wu Z; Yang C; Shen Y and 17 more (2023) - Transparency Score: 4/6
A 14+7 day quarantine period and a dual nucleic acid testing reagent strategy detect potentially in…
Wang YJ; Xue JH; Fang ZX and 4 more (2022) - Transparency Score: 3/6
A haemochromatosis-causing HFE mutation is associated with SARS-CoV-2 susceptibility in the Czech p…
Hubacek JA; Philipp T; Adamkova V and 2 more (2022) - Transparency Score: 3/6
Angiotensin-converting enzyme 1 and voltage-gated potassium channel-interacting protein 4 gene poly…
Abbaszadeh H; Mohammadi F; Rajabi-Moghaddam M and 4 more (2022) - Transparency Score: 3/6
At-admission HbA<sub>1c</sub> levels in hospitalized COVID-19 participants with and without known d…
Valle A; Rodriguez J; Camiña F and 3 more (2022) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"appendix a supplementary material the following are the supplementary data to this article: supplementary data 1 appendix a supplementary data to this article can be found online at https://doi org/10 1016/j cca 2020 06 008 ."

Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declared that there is no conflict of interest."

Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025